Lung GGO Insights
DR. CHING-YANG WU
Lung GGO describes a lesion with higher tissue density, appearing as grayish areas on CT scans.
It’s not always lung cancer; it can also result from inflammation, fibrosis, or benign tumors.
Lung cancer is just one possible cause.
Whether surgery is needed depends on a thoracic surgeon’s professional evaluation of the lesion’s size and density.
About DR. CHING-YANG WU
- Thoracic Surgeon, Linkou Chang Gung
- Associate Professor, Chang Gung University
- Associate Professor, Chang Gung Hospital
- Instructor, Thoracic & Cardiovascular Surgery Association
- Instructor, Thoracic Surgery Association
Clinical Experience
SERVICEKey Facts About GGO
Lung GGO can be worrying, but early treatment and regular follow-ups can effectively manage it.
Here are key insights about GGO, explained by Dr. Wu:
Key Factors for GGO Surgery
Whether lung GGO requires surgery depends on its size and density.
Medical consensus recommends active treatment for GGOs larger than 0.7–0.8 cm.
For GGOs between 0.5–0.7 cm, density becomes the deciding factor.
CT imaging evaluates density, with a lesion considered high-density if the ratio of its solid component diameter to total diameter exceeds 50%.
Patients with a family history of lung cancer or a smoking history are also advised to confirm the diagnosis through biopsy.
Non-Surgical GGO Management
If surgery is not immediately required, the thoracic surgeon will recommend regular CT imaging to monitor changes in the GGO:
a. <0.5 cm: Follow-up every 6–12 months
b. 0.5–0.7 cm, density <50%: Follow-up every 3–6 months
c. 0.5–0.7 cm, density >50%: Follow-up every 3 months
If the GGO remains stable for two years, annual follow-ups may be sufficient.
Consistent imaging settings (e.g., slice thickness) are advised for accurate comparisons.
GGO Diagnosis: CT-Guided Biopsy
There are 3 methods to diagnose lung GGO, depending on its location and density.
CT-guided biopsy uses real-time imaging to target and sample the lesion.
For small lesions or those deep in the lung, near fissures, or close to major blood vessels, results may be inconclusive, requiring alternative diagnostic methods.
Possible complications include pneumothorax, hemothorax, or air embolism if the lesion is near blood vessels.
Preoperative imaging can help minimize these risks.
GGO Diagnosis: Bronchoscopic Biopsy
Bronchoscopic biopsy uses a bronchoscope or ultrasound guidance to sample GGO tissue.
This method is limited to lesions within or near the bronchial tree or adjacent lymph nodes.
GGO Diagnosis: Surgical Biopsy
Surgical biopsy is performed when a GGO is highly suspected to be malignant, with no other suspicious lesions and the patient is fit for curative resection.
This approach allows for a definitive diagnosis while enabling immediate treatment if malignancy is confirmed through intraoperative frozen biopsy, reducing the need for multiple procedures.
High-Risk Malignant GGO
Thoracic surgeons first perform a thoracoscopic biopsy of the GGO.
If intraoperative frozen biopsy confirms malignancy, curative resection is conducted through a single-port thoracoscopy, based on preoperative imaging and the patient’s heart and lung function.
GGO Surgery Process
-
1
GGO Imaging Diagnosis
Use CT-guided biopsy to assess GGO size and severity.
-
2
GGO Surgery Planning
Plan surgery based on GGO size and location.
-
3
GGO Surgery Execution
Remove GGO with minimal functional impact.
-
4
GGO Margin Assessment
Check for air leaks and place a chest drain.
-
5
GGO Follow-Up Plan
Create a follow-up plan with imaging comparisons.
Lung GGO Q&A
Top Questions About Lung GGO, Answered!
What if a Lung GGO is Diagnosed as Malignant?
If a GGO is confirmed malignant through CT or bronchoscopic biopsy, a thoracic surgeon will arrange PET scans and brain MRIs.
These tests assess the severity, including tumor size, lymph node involvement, and possible metastasis, to determine if curative surgery is viable.
What is the Surgical Process for Malignant GGO?
If a GGO is suitable for curative resection, preoperative evaluations assess heart and lung function to determine the resectable lung volume without impairing function.
The surgery is planned to minimize harm, with preoperative CT simulations and tumor localization ensuring safety.
For malignant GGOs, mediastinal lymph node dissection is performed during surgery.
Is Follow-Up Needed After GGO Surgery?
Yes, follow-up is typically required to monitor recovery.
The exact plan depends on the final pathology results.
Discuss with your doctor to ensure optimal post-surgery care.
Lung Tumor Surgery Risks and Alternatives?
Surgery is the best option for malignant tumors if heart and lung function allow for complete resection.
If the biopsy is inconclusive or the tumor is benign, further biopsy or regular imaging follow-up for 2–3 years may be considered.
Get GGOTreatment Now
Specialized Excellence
Trusted Thoracic Care
Dedicated specialists and a trusted team for superior care.
Personalized Surgical Plans
Tailored strategies to minimize functional loss.
Advanced Surgical Skills
Mastery in single-port and robotic thoracic procedures.
Extensive Clinical Expertise
Skilled in treating lung and mediastinal conditions.
Patient-Centered Safety
Tailored care to minimize risks and surgical impact.
Postoperative Monitoring
Ongoing care to ensure no recurrence.
PressCoverage
嘉大攜手林口長庚 突破大細胞肺癌治療困境
林口長庚醫院胸腔外科醫師吳青峰、吳青陽團隊,攜手投入大細胞肺癌治療研究,經2年多實驗成果,顯著發現1種花青素Cyanidin 3-O-glucoside可有效抑制大細胞肺癌腫瘤增長...
吳青陽醫師獲 ASCVTS 2016 的 AATS Graham Award
吳青陽醫師在大會規定的 12 分鐘內(10 分鐘論文研究報告 + 2 分鐘 Q&A),在 Originality、Future Application、Contents、Logicality、Presentation 等 5 項評比項目表現優異,獲得 AATS Graham Award...
吳青陽醫師團隊,比較三種 CT 引導技術應用於肺部病灶定位之研究,獲 European Journal of Radiology 刊登!
吳青陽醫師團隊展開研究,收集 2019 年 9 月至 2021 年 8 月期間,共 418 位肺部病變的患者,並對電腦斷層掃描(CT)引導的肺部病灶定位技術:金屬線定位、染料紋身定位...
吳青陽醫師團隊,關於腫瘤護理人員透過 3D 模擬訓練以提升使用植入式靜脈導管意願之研究,獲 Seminars in Oncology Nursing 刊登!
植入式靜脈導管無法直接被護理人員肉眼辨識,只能透過手動觸摸來識別。這種缺乏可視性的狀況,可能導致臨床流程操作不當。為了減少這些操作風險,吳青陽醫師團隊設計了一個互動視覺訓練課程和 3D 模擬器供參與者使用,並給予問卷評估課程的效果...
吳青陽醫師植入式注射座研究文章,獲 medicine 刊登!
吳醫師根據文獻、自己的臨床經驗,制訂了一個「標準流程 (standard algorithm)」來評估「最佳進入血管 (best entry vessel)」,並長時間根據這方法來協助患者...
吳青陽醫師之肺癌研究文章,獲 medicine 刊登!
在吳青陽醫師的經驗中,還是有不少的患者復發非小細胞肺癌。於是,吳醫師與其團隊,回顧 2005 到 2011 年共 356 位第一期肺癌患者,其五年復發率為 41.1%,收集其特性...
吳青陽醫師團隊,關於小於兩公分的肺腺癌預後研究,獲 Journal of the Formosan Medical Association 刊登!
吳致瑩與吳青陽醫師團隊,預計使用回溯性研究,看看是否有獨特的預後因子,在臨床上有應用價值。研究回溯了台中榮總與長庚醫院 2007 到 2015 的病例,診斷為 2 公分以下的肺腺癌...
吳青陽醫師團隊,以手術後血液中的循環腫瘤細胞,預測肺癌復發之研究,獲 Diagnostics 刊登!
吳青陽醫師團隊,經常作肺癌手術,於是他們思考到,如果能利用 CTC 的變化(而非絕對數目),去預測患者手術後會不會復發,或許能對患者...
吳青陽醫師關於中央靜脈導管之尖端置放位置的研究,獲 medicine 刊登!
吳醫師研究 346 個案例後發現,有 221 例 (63.9%) 為 nonmigration group、有 67 例 (19.4%) 為 peripheral movement group、有 58 例 (16.8%) 為 central movement group...
吳青陽醫師研發新型「植入式人工注射座」之論文,獲 Journal of Biomedical Materials Research Part B: Applied Biomaterials 刊登!
吳青陽醫師對植入式人工注射座 (intravenous port) 有深入的系列研究與豐富的臨床經驗,除了探討相關合併症、提出改善策略,在本篇論文中吳醫師進一步研發新的注射座設計,希望從源頭解決...
Dr. Wu’s Expertise
- 2011 Taiwan Thoracic & Cardiovascular Surgery New Scholar Award
- 2012 Taiwan Thoracic & Cardiovascular Surgery President’s Award
- 2014 Taiwan Vascular Surgery Smart Award
- 2015 Taiwan Vascular Surgery Smart Award
- 2016 AATS Graham Award
- 2020 Taiwan Thoracic & Critical Care Medicine Best Paper
- 2021 Taiwan Thoracic & Cardiovascular Surgery President’s Award
- 2023 Global Injection Port Consensus Conference
InfoVideo
什麼是植入式注射座?
植入式注射座的分類方式可以從導管材質,功能上可否承受高壓注射,注射座材質進行初步區分。從導管材質來看主要是可區分為矽膠...
醫護人員如何經由可承受高壓的植入式注射座打藥(顯影劑)
使用可承受高壓的植入式注射座的辨識以及穿刺程序說明...
植入式注射座的術後相關注意事項簡介
植入式注射座置放之後,基本日常生活所進行的活動都不受限制(吃飯,穿衣,睡覺,作家事,抱小孩等)。所需注意的動作與注射座的置放位置...
植入式注射座置放手術實際狀況
植入式靜脈注射座(即俗稱的人工血管)在臨床治療上主要作為一個可靠的靜脈注射通路。打個比方就是在病患身上置放一個隱型插座,用於腫瘤治療的注射針具就像插頭...